C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2011
03/22/2011	CA2464713C A peptide-based fluorescence polarization assay for detection of antibodies to mycobacterium bovis
03/22/2011	CA2461380C Hepatitis c virus vaccine
03/22/2011	CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof
03/22/2011	CA2412050C A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
03/22/2011	CA2396519C A process for isolation of osteopontin from milk
03/22/2011	CA2390166C Hedgehog fusion proteins and uses
03/22/2011	CA2308127C Agonist and antagonist peptides of carcinoembryonic antigen (cea)
03/22/2011	CA2306229C Positive-negative selection for homologous recombination
03/22/2011	CA2272844C Novel nucleic acid molecules from maize and their use for the production of modified starch
03/22/2011	CA2240409C Mammalian cx3c chemokine genes
03/22/2011	CA2236159C Vp antigens of the jc virus
03/22/2011	CA2223013C Methods of raising antibodies against e.coli of the family cs4-cfa/1
03/22/2011	CA2173750C Single-chain forms of the glycoprotein hormone quartet
03/22/2011	CA2136958C Method for inhibition of viral morphogenesis
03/17/2011	WO2011032022A1 Improved pseudomonas exotoxin a with reduced immunogenicity
03/17/2011	WO2011031986A1 Assays for soluble il-15 receptor alpha
03/17/2011	WO2011031835A1 Chimeric dr5 polypeptides and uses thereof
03/17/2011	WO2011031187A1 Antimicrobial agents based on hemin derivatives
03/17/2011	WO2011031139A1 An ataq protein or a part thereof as a vaccine
03/17/2011	WO2011031125A1 Recombinant proteins that can be expressed in escherichia coli as active ingredients of vaccines against 2009 outbreak h1n1 influenza a, and production method thereof
03/17/2011	WO2011030895A1 Mouse pheromone
03/17/2011	WO2011030890A1 Method for detection and activity measurement of proteinkinase
03/17/2011	WO2011030682A1 Construct coated with virus coat-constituting protein and method for producing same
03/17/2011	WO2011030300A1 Synthetic peptides from the sv40 t-antigen for use in an indirect elisa test for the identification of antibodies against simian virus 40 in human serum and other fluids
03/17/2011	WO2011030296A1 Molecules capable of inducing cell death by targeting the mitochondria and applications thereof
03/17/2011	WO2011030218A1 Combination vaccines against respiratory tract diseases
03/17/2011	WO2011029980A1 Therapeutic compositions for the treatment of hpv-induced diseases
03/17/2011	WO2011029881A2 A method for binding a recombinant polypeptide to a carrier
03/17/2011	WO2011029870A1 Use of interleukin-1 beta mutein conjugates in the treatment of diabetes
03/17/2011	WO2011029869A1 Hypoallergenic hybrid polypeptides for the treatment of allergy
03/17/2011	WO2011029866A2 Polymerase compositions and uses
03/17/2011	WO2011029861A1 Plgf-1 in homodimeric form
03/17/2011	WO2011011688A3 DENDRITIC CELL VACCINES FOR ASPARAGINYL- β - HYDROXYLASE EXPRESSING TUMORS
03/17/2011	WO2011001286A3 Expression of transcription regulators that provide heat tolerance
03/17/2011	WO2011001086A3 Use of interfering rna for treating an hiv infection
03/17/2011	WO2010136841A3 Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof
03/17/2011	WO2010134096A3 Yeast strain expressing modified human cytochrome p450 reductase and/or cytochrome p450 gene
03/17/2011	WO2010134095A3 Yeast strain expressing modified human cytochrome p450 reductase and/or cytochrome p450 gene
03/17/2011	WO2010129789A3 Modified tumor necrosis factor-beta
03/17/2011	WO2010129784A3 Isolated a-type fhf n-terminal domain peptides and methods of use
03/17/2011	WO2010128338A3 Use of herpes simplex virus particles for the expression of antigens
03/17/2011	WO2010122367A3 Meganuclease variants cleaving the genomic insertion of a virus and uses thereof
03/17/2011	WO2010120069A3 Antigenic protein of black-lip pearl oyster egg extract, and method for assessing productive effort of black-lip pearl oyster using antibody specific to the protein
03/17/2011	WO2009146886A9 Antibacterial peptides
03/17/2011	US20110067148 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
03/17/2011	US20110067121 Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications
03/17/2011	US20110066251 Anti-angiogenic compositions and methods of use
03/17/2011	US20110066230 Fluorinated GHRH Antagonists
03/17/2011	US20110065898 Immunosuppressant Target Proteins
03/17/2011	US20110065896 Polyether polyol dendron conjugates with effector molecules for biological targeting
03/17/2011	US20110065862 Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith
03/17/2011	US20110065661 Pharmacoperones for correcting disease states involving protein misfolding
03/17/2011	US20110065653 Tat-utrophin as a protein therapy for dystrophinopathies
03/17/2011	US20110065649 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
03/17/2011	US20110065647 Novel peptides isolated from spider venom, and uses thereof
03/17/2011	US20110065641 Polypeptide and dna thereof useful as a neovascular marker
03/17/2011	US20110065640 Anti-invasive and anti-angiogenic compositions
03/17/2011	US20110065638 Novel crustacean androgenic gland hormone
03/17/2011	US20110065636 Screening and Therapy for Lymphatic Disorders Involving the FLT4 Receptor Tyrosine Kinase (VEGFR-3)
03/17/2011	US20110065633 Ester-based peptide prodrugs
03/17/2011	US20110065632 Pharmaceutical compositions of somatostatin-dopamine conjugates
03/17/2011	US20110065600 Sequences associated with tdp-43 proteinopathies and methods of using the same
03/17/2011	US20110065587 Epitope testing using soluble hla
03/17/2011	US20110065210 Use of B-Type Natriuretic Peptide as a Prognostic Indicator in Acute Coronary Syndromes
03/17/2011	US20110065206 Thrombospondin Fragments and Uses Thereof in Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents
03/17/2011	US20110065198 Novel targets and compounds for therapeutic intervention of hiv infection
03/17/2011	US20110065197 Diagnostic kit for alzheimer's disease, diagnostic marker, and detection method for indicator of pathological state thereof
03/17/2011	US20110065179 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
03/17/2011	US20110065178 Dendritic cell potentiation
03/17/2011	US20110065177 Novel Collectin
03/17/2011	US20110065175 Artificially synthesized peptide
03/17/2011	US20110065174 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene
03/17/2011	US20110065173 Vector
03/17/2011	US20110065148 Peptides and uses thereof
03/17/2011	US20110065147 Methods and reagents for modulating cholesterol levels
03/17/2011	US20110065146 Expression of HIV polypeptides and production of virus-like particles
03/17/2011	US20110065134 Synthetic peptides immuno-reactive with rheumatoid arthritis auto-antibodies
03/17/2011	US20110065132 Identification of Actinobacillus actinomycetemcomitans Antigens for use in the Diagnosis, Treatment and Monitoring of Periodontal Diseases
03/17/2011	US20110065124 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
03/17/2011	US20110065107 Detection of gleevec resistance
03/17/2011	US20110065102 Osteoarthritis-sensitive gene
03/17/2011	US20110065091 Coronavirus, Nucleic Acid, Protein, and Methods for the Generation of Vaccine, Medicaments and Diagnostics
03/17/2011	US20110065089 Novel strain of sars-associated coronavirus and applications thereof
03/17/2011	US20110064793 Inhibitors of hiv replication and method of treatment of hiv infections
03/17/2011	US20110064782 Methods and compositions for tissue regeneration
03/17/2011	US20110064761 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
03/17/2011	US20110064759 Method for the Identification of Extracellular Domains of Epstein Barr Virus (EBV) Tumor-Associated Latent Membrane Proteins and for the Selection of Antibody Reagents Reactive Therewith
03/17/2011	US20110064758 Infectious clones of torque teno virus
03/17/2011	US20110064757 Nucleic acid molecules and polypeptides for immune modulation
03/17/2011	US20110064756 Novel sequences of brachyspira, immunogenic compounds, methods for preparation and use thereof
03/17/2011	US20110064751 Targeted immunoconjugates
03/17/2011	US20110064741 Stable amyloid beta monomers and oligomers
03/17/2011	US20110064733 Ca6 antigen-specific cytotoxic conjugate and methods of using the same
03/17/2011	US20110064728 IL-17 Homologous Polypeptides and Therapeutic Uses Thereof
03/17/2011	US20110064719 Hydrophobic interaction chromatography purification of factor vii polypeptides
03/17/2011	US20110064690 Pegylated Interleukin-10
03/17/2011	US20110064689 In situ immunization
03/17/2011	US20110064668 J-superfamily conotoxin peptides
03/17/2011	US20110064667 Azide modified proteins
03/17/2011	US20110064663 Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, compositions and methods of use

1 ... 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 ... 2916